They announced the closure after learning that Stephanie Vetter was accepted into an experimental trial at the University of Wisconsin-Madison to use T-cells to treat cancer.
“We’re looking forward to the treatment,” Vetter said. “The trial is being used in blood cancer with great success. We’ll see if it will work with solid-state tumors, as well.”